NSN 6505-01-717-0530 · NIIN 017170530 · FSC 6505
NO DASHES 6505017170530
In Stock
BUDESONIDE INHALATION SUSPENSION
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | BREYNA 160-4.5MCG INH 120 (BUDESONIDE/FORMOTEROL HFA 160-4.5MCG) |
| FEAT | SPECIAL FEATURES | INDICATED FOR THE TREATMENT OF ASTHMA IN PATIENTS 6 YEARS OF AGE AND OLDER; GENERIC SYMBICORT TO CONTROL AND PREVENT SYMPTOMS CAUSED BY ASTHMA AND LUNG DISEASE. BUDESONIDE IS A CORTICOSTEROID THAT REDUCES INFLAMMATION AND SWELLING OF THE AIRWAYS AND FORMOTEROL IS A LONG-ACTING BETA AGONIST THAT RELAXES MUSCLES AROUND THE AIRWAY. INHALER MUST BE PRIMED BEFORE USE OR AFTER GOING UNUSED FOR 7 OR MORE DAYS. STORE AT CONTROLLED ROOM TEMPERATURE (68-77 DEGREES F) AND DISCARD INHALER 3 MONTHS AFTER YOU REMOVE IT FROM ORIGINAL FOIL PACKAGING. HAZMAT PRODUCT; FOR ORAL INHALATION ONLY; CONTENTS: EACH CARTON CONTAINS ONE CANISTER. NET FILL WEIGHT 10.3 G. PROVIDING 120 INHALATIONS. |